Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 7
Submit an article Journal homepage
295
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Randomized phase 1 study of sequential (“primed”) vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm

Raffaele PalmieriClinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA; View further author information
,
Sarah A. BuckleyClinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA; View further author information
,
Megan OthusPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; View further author information
,
Anna B. HalpernClinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA; ;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; View further author information
,
Mary-Elizabeth M. PercivalClinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA; ;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; View further author information
,
Bart L. ScottClinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA; ;Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA; View further author information
,
Paul C. HendrieDepartment of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; ;Seattle Cancer Care Alliance, Seattle, WA, USA; View further author information
,
Pamela S. BeckerClinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA; ;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; View further author information
,
Vivian G. OehlerClinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA; ;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; View further author information
,
Elihu H. EsteyClinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA; ;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; View further author information
&
Roland B. WalterClinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, USA; ;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA; ;Department of Pathology, University of Washington, Seattle, WA, USA; ;Department of Epidemiology, University of Washington, Seattle, WA, USACorrespondence[email protected]
View further author information
 show all
Pages 1728-1731 | Received 01 Jan 2020, Accepted 07 Feb 2020, Published online: 20 Feb 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The conduct of the clinical trial was partially funded by Protocol Specific Research Support from the Fred Hutchinson/University of Washington Cancer Consortium Cancer Center Support Grant of the National Institutes of Health (P30-CA015704). S.A.B. was supported by a fellowship training grant from the National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH: T32-HL007093). The funding sources played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. Clinicaltrials.gov identifier: NCT02921061

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.